Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GenSci048 in endometriosis-associated pain
NCT06963177Phase 2Recruiting
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- May 2025
- Primary completion
- May 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of genakumab in endometriosis, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started May 2025; status: recruiting.
02
Drugs
genakumab
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT06963177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06963177.